Clinical Trial Update: Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial [NA]

View source ↗

Summary

This completed clinical trial update discusses evaluating BOSCC and ELSA as outcome measures within a JASPER autism intervention study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: University of California, Los Angeles | Conditions: Autism Spectrum Disorder | NA | Status: COMPLETED